NevadaSB38983rd Regular Session (2025)SenateWALLET

AN ACT relating to prescription drugs; requiring the Department of Health and Human Services to select and contract with a state pharmacy benefit manager to manage pharmacy benefits for Medicaid and certain other health benefit plans; requiring the Department to establish certain methodologies for the payment of and rates of reimbursement for prescription drugs under Medicaid; requiring the Department to establish a benchmark to measure certain data relating to the cost of prescription drugs; prescribing certain duties of the state pharmacy benefit manager; requiring that the Department approve certain contracts entered into by the state pharmacy benefit manager; prohibiting the state pharmacy benefit manager from engaging in certain activities; requiring a Medicaid managed care organization to contract with and utilize the state pharmacy benefit manager to manage pharmacy benefits; requiring a Medicaid managed care organization to provide certain information to the Department upon request; and providing other matters properly relating thereto.

Sponsored By: Jeff Stone (Republican), Melanie Scheible (Democratic)

Signed by Governor

BDR 38-240

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

6 provisions identified: 3 benefits, 0 costs, 3 mixed.

Cancer patients can skip step therapy

Beginning January 1, 2030, a Nevada Medicaid recipient with stage 3 or 4 cancer can ask to skip step therapy. You, your doctor, or a designated advocate can apply and give clinical reasons. A qualified doctor, nurse, or pharmacist reviews it. The reviewer must decide within 72 hours, or faster if your doctor says delay could seriously harm you. The agency, PBM, and HMOs must post an easy online form and tell you the reviewers’ qualifications. If approved, the State pays the nonfederal share. Coverage may start with a 1‑week supply and continue if it works, with reviews no more than once per quarter and a report sent to you.

Single state manager for Medicaid drugs

Starting January 1, 2030, the Department selects and contracts with a single state pharmacy benefit manager to run drug benefits. Medicaid managed care plans must use this manager and give the Department spending details when asked. Contracts must follow all state and federal laws and require the manager to negotiate purchases for drugs on the preferred list unless another contract covers them. The first contract must start by January 1, 2030. Parts of the law take effect earlier only to let the Department write rules and prepare.

Stronger rules and full drug rebate pass-through

Beginning January 1, 2030, the state’s drug benefit manager must give the Department 100% of all drug rebates. Contracts ban spread pricing, pharmacy steering, and required mail‑order, and they must not pay less than the State’s approved dispensing fee. The manager and HMOs must disclose fees, rebates, and cost controls, and submit to yearly audits the Department posts online. The Department also sets a preferred drug list and posts a yearly report by February 1 on the contracts’ financial effects.

New Medicaid pharmacy pay and fees

The Department sets how pharmacies are paid and the dispensing fees for Medicaid, with separate rules for pharmacies owned by 340B covered‑entity facilities. Fees can differ by pharmacy type where federal law allows. Payment aims to use a drug’s actual acquisition cost and the Nevada Average Acquisition Cost benchmark if the Department establishes one. These changes can lower program costs and also change pharmacy revenue.

Medicaid rules for 340B drug discounts

Beginning January 1, 2030, some 340B protections do not apply when the state’s drug manager runs Medicaid pharmacy benefits. The Department and Medicaid plans may set terms to prevent duplicate discounts and protect Medicaid finances. This can change how 340B providers are paid and how networks operate.

Nevada drug price benchmark and data

The Department may set a Nevada Average Acquisition Cost benchmark only if it will reduce State spending. It can use surveys and data from the state’s drug manager to set it, and must report savings to lawmakers every two years by February 1. Providers that run pharmacies for 340B covered entities must send claims data on actual drug acquisition costs as the Department requires.

Sponsors & Cosponsors

Sponsors

  • Jeff Stone

    Republican • Senate

  • Melanie Scheible

    Democratic • Senate

Cosponsors

  • Skip Daly

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 59 • No: 2

House vote • 5/31/2025

Final Passage - Assembly (2nd Reprint)

Yes: 41 • No: 0

Senate vote • 5/26/2025

Final Passage - Senate (2nd Reprint)

Yes: 18 • No: 2

Actions Timeline

  1. Chapter 390.

    6/6/2025legislature
  2. Approved by the Governor.

    6/6/2025legislature
  3. Enrolled and delivered to Governor.

    6/4/2025legislature
  4. To enrollment.

    6/2/2025Senate
  5. In Senate.

    6/1/2025Senate
  6. Read third time. Passed. Title approved. (Yeas: 41, Nays: None, Excused: 1.) To Senate.

    5/31/2025House
  7. Read second time.

    5/30/2025House
  8. Placed on Second Reading File.

    5/30/2025House
  9. From committee: Do pass.

    5/30/2025House
  10. Read first time. Referred to Committee on Commerce and Labor. To committee.

    5/27/2025House
  11. In Assembly.

    5/27/2025House
  12. From printer. To re-engrossment. Re-engrossed. Second reprint. To Assembly.

    5/27/2025Senate
  13. Read third time. Passed, as amended. Title approved, as amended. (Yeas: 18, Nays: 2, Excused: 1.) To printer.

    5/26/2025Senate
  14. Reprinting dispensed with.

    5/26/2025Senate
  15. Read third time. Amended. (Amend. No. 725.)

    5/26/2025Senate
  16. Placed on General File.

    5/26/2025Senate
  17. From committee: Amend, and do pass as amended.

    5/26/2025Senate
  18. From printer. To engrossment. Engrossed. First reprint. To committee.

    4/24/2025Senate
  19. Taken from General File. Re-referred to Committee on Finance. Exemption effective. To printer.

    4/21/2025Senate
  20. Notice of eligibility for exemption.

    4/21/2025Senate
  21. Read second time. Amended. (Amend. No. 465.)

    4/21/2025Senate
  22. Placed on Second Reading File.

    4/21/2025Senate
  23. From committee: Amend, and do pass as amended.

    4/21/2025Senate
  24. From printer. To committee.

    3/18/2025Senate
  25. Read first time. Referred to Committee on Health and Human Services. To printer.

    3/17/2025Senate

Bill Text

Related Bills

Back to State Legislation